Clinical decision support improves physician guideline adherence for laboratory monitoring of chronic kidney disease: a matched cohort study

From Clinfowiki
Revision as of 02:17, 22 October 2015 by Sibekwe (Talk | contribs)

Jump to: navigation, search

Background

The implementation of existing clinical guidelines for Chronic Kidney Disease (CKD) is inadequate. This article evaluates how guideline-based Clinical Decision Support System (CDSS) affects laboratory monitoring of patients with Stage 3-4 Chronic Kidney Disease, an attaining laboratory goals in those patients. [1]

Methods

Results

Conclusions

Appendix

  • Lab measurement frequency and range targets used in the analysis. [2]
  • Baseline patient characteristics. [3]
  • Estimated odds ratio for ordering laboratory tests within guideline-recommended intervals: CDSS vs Controls. [4]
  • Effect of CDSS on adherence to guideline testing intervals for eGFR. [5]
  • Effect of CDSS on adherence to guideline testing intervals for phosphorus (a) and PTH (b). [6]
  • Effect of CDSS on adherence to guideline testing intervals for LDL-C (a) and Urine Panels (b). [7]
  • Effect of CDSS on achievement of guideline targets for LDL cholesterol (a) and 25-D (b). [8]
  • Estimated odds ratio for achieving guideline-recommended laboratory test targets: CDSS vs Controls. [9]

My Comments

References

  1. ↑ Ennis, J., Gillen, D., Rubenstein, A., Worcester, E., Brecher, M. E., Asplin, J., & Coe, F. (2015). Clinical decision support improves physician guideline adherence for laboratory monitoring of chronic kidney disease: a matched cohort study. BMC nephrology, 16(1), 163. http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4608162/
  2. ↑ Lab measurement frequency and range targets used in the analysis. http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4608162/table/Tab1/
  3. ↑ Baseline patient characteristics http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4608162/table/Tab2/
  4. ↑ http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4608162/table/Tab3/
  5. ↑ Effect of CDSS on adherence to guideline testing intervals for eGFR. http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4608162/figure/Fig1/
  6. ↑ Effect of CDSS on adherence to guideline testing intervals for phosphorus (a) and PTH (b). http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4608162/figure/Fig2/
  7. ↑ Effect of CDSS on adherence to guideline testing intervals for LDL-C (a) and Urine Panels (b). http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4608162/figure/Fig3/
  8. ↑ Effect of CDSS on achievement of guideline targets for LDL cholesterol (a) and 25-D (b). http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4608162/figure/Fig4/
  9. ↑ Estimated odds ratio for achieving guideline-recommended laboratory test targets: CDSS vs Controls. http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4608162/table/Tab4/
Retrieved from "http://www.clinfowiki.org/wiki/index.php?title=Clinical_decision_support_improves_physician_guideline_adherence_for_laboratory_monitoring_of_chronic_kidney_disease:_a_matched_cohort_study&oldid=27944"